Prognostic value of brain natriuretic peptide in noncardiac surgery: A meta-analysis

Anesthesiology

Volumn 111, Issue 2, 2009, Pages 311-319

  Ryding, Alisdair D S ^a   Kumar, Saurabh ^b   Worthington, Angela M ^b   Burgess, David ^b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; META ANALYSIS; MORTALITY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REFERENCE DATABASE; RISK FACTOR; SURGERY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW;

EID: 68249147569     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181aaeb11     Document Type: Article

References (32)

1. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:e418-99
2. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Malaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P: Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial. Lancet 2008; 371:1839-47
3. Weidemann A, Klanke B, Wagner M, Volk T, Willam C, Wiesener MS, Eckardt KU, Warnecke C: Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J 2008; 409:233-42
4. Alter P, Rupp H, Rominger MB, Vollrath A, Czerny F, Figiel JH, Adams P, Stoll F, Klose KJ, Maisch B: B-type natriuretic peptide and wall stress in dilated human heart. Mol Cell Biochem 2008; 314:179-91
5. Weber M, Hamm C: Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006; 92:843-9
6. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology. A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-12
7. Oxman AD: Checklists for review articles. BMJ 1994; 309:648-51
8. Sterne JA, Egger M: Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clin Epidemiol 2001; 54:1046-55
9. Sterne JA, Juni P, Schulz KF, Altman DG, Bartlett C, Egger M: Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research. Stat Med 2002; 21:1513-24
10. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG: Development and validation of MIX: Comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006; 6:50
11. Yeh HM, Lau HP, Lin JM, Sun WZ, Wang MJ, Lai LP: Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery. Br J Surg 2005; 92:1041-5
12. Cuthbertson BH, Card G, Croal BL, McNeilly J, Hillis GS: The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non-cardiac surgery. Anaesthesia 2007; 62:875-81
13. Descamps M, Ryding ADS, Jeilan M, Bankart J, Crawfurd EJP, Gidden DJ, Sprigings DC: Plasma brain natriuretic peptide predicts outcome in patients with fractured neck of femur. Heart 2007; 93:A77
14. Leibowitz D, Planer D, Rott D, Elitzur Y, Chajek-Shaul T, Weiss AT: Brain natriuretic peptide levels predict perioperative events in cardiac patients undergoing noncardiac surgery: A prospective study. Cardiology 2007; 110:266-70
15. Cho D, Choi JO, Park MJ, Yang JH, Lee SC, Jeon ES, Lee SH, Choi JH: Plasma NT-proBNP can predict perioperative cardiac events in patients undergoing noncardiac surgery. Eur Heart J Suppl 2007:P1450
16. Cuthbertson BH, Amiri AR, Croal BL, Rajagopalan S, Alozairi O, Brittenden J, Hillis GS: Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth 2007; 99:170-6
17. Dernellis J, Panaretou M: Assessment of cardiac risk before non-cardiac surgery: Brain natriuretic peptide in 1,590 patients. Heart 2006; 92:1645-50
18. Gibson SC, Payne CJ, Byrne DS, Berry C, Dargie HJ, Kingsmore DB: B-type natriuretic peptide predicts cardiac morbidity and mortality after major surgery. Br J Surg 2007; 94:903-9
19. Yun KH, Jeong MH, Oh SK, Choi JH, Rhee SJ, Park EM, Yoo NJ, Kim NH, Ahn YK, Jeong JW: Preoperative plasma N-terminal pro-brain natriuretic peptide concentration and perioperative cardiovascular risk in elderly patients. Circ J 2008; 72:195-9
20. Berry C, Kingsmore D, Gibson S, Hole D, Morton JJ, Byrne D, Dargie HJ: Predictive value of plasma brain natriuretic peptide for cardiac outcome after vascular surgery. Heart 2006; 92:401-2
21. Feringa HH, Bax JJ, Elhendy A, de Jonge R, Lindemans J, Schouten O, van den Meiracker AH, Boersma E, Schinkel AF, Kertai MD, van Sambeek MR, Poldermans D: Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Am J Cardiol 2006; 98:111-5
22. Feringa HH, Schouten O, Dunkelgrun M, Bax JJ, Boersma E, Elhendy A, de Jonge R, Karagiannis SE, Vidakovic R, Poldermans D: Plasma N-terminal pro-Btype natriuretic peptide as long-term prognostic marker after major vascular surgery. Heart 2007; 93:226-31
23. Goei D, Schouten O, Boersma E, Welten GM, Dunkelgrun M, Lindemans J, van Gestel YR, Hoeks SE, Bax JJ, Poldermans D: Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. Am J Cardiol 2008; 101:122-6
24. Mahla E, Baumann A, Rehak P, Watzinger N, Vicenzi MN, Maier R, Tiesenhausen K, Metzler H, Toller W: N-terminal pro-brain natriuretic peptide identifies patients at high risk for adverse cardiac outcome after vascular surgery. ANESTHESIOLOGY 2007; 106:1088-95
25. Riemersma M, Dijkstra PU, van Veldhuisen DJ, Muskiet FA, van den Dungen JA, Geertzen JH: Mortality and preoperative cardiac function in vascular amputees. An N-terminal pro-brain natriuretic peptide (NT-proBNP) pilot study. Clin Rehabil 2008; 22:56-9
26. Cuthbertson BH, Amiri AR, Croal BL, Rajagopalan S, Brittenden J, Hillis GS: Utility of B-type natriuretic peptide in predicting medium-term mortality in patients undergoing major non-cardiac surgery. Am J Cardiol 2007; 100:1310-3
27. Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E: B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: An ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004; 44:335-9
28. Balion C, Santaguida PL, Hill S, Worster A, McQueen M, Oremus M, McKelvie R, Booker L, Fagbemi J, Reichert S, Raina P: Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. Evid Rep Technol Assess (Full Rep) 2006:1-147
29. Oremus M, Raina PS, Santaguida P, Balion CM, McQueen MJ, McKelvie R, Worster A, Booker L, Hill SA: A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease. Clin Biochem 2008; 41:260-5
30. Galasko GI, Lahiri A, Barnes SC, Collinson P, Senior R: What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J 2005; 26:2269-76
31. Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F: The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003; 89:745-51
32. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr: Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002; 40:976-82